Literature DB >> 24673297

A longitudinal study of Babesia microti infection in seropositive blood donors.

David A Leiby1, Stephanie T Johnson, Kimberly Y Won, Eva K Nace, Susan B Slemenda, Norman J Pieniazek, Ritchard G Cable, Barbara L Herwaldt.   

Abstract

BACKGROUND: Babesia infection is caused by intraerythrocytic tick-borne parasites. Cases of transfusion-transmitted babesiosis have been increasingly recognized. To date, no Babesia test has been licensed for screening US blood donors. We conducted a longitudinal study to assess the course and markers of Babesia infection among seropositive donors identified in a seroprevalence study. STUDY DESIGN AND METHODS: Eligible donors had B. microti indirect fluorescent antibody (IFA) titers of 64 or greater. Enrollees were monitored up to 3 years, by IFA and three methods for evidence of parasitemia: B. microti nested polymerase chain reaction (PCR) analysis (at two laboratories), hamster inoculation, and blood-smear examination.
RESULTS: Among 115 eligible donors, 84 (73%) enrolled. Eighteen enrollees (21%) had evidence of parasitemia for 30 total specimens (17% of 181), which were collected in 9 different months and tested positive by various approaches: PCR (25 specimens/16 persons), hamster inoculation (13 specimens/8 persons), and blood smear (one specimen positive by all three approaches). Overall, 14 persons had one or more specimen with positive PCR results at both laboratories (12 persons) and/or had parasitologically confirmed infection (eight persons). Three of nine persons who had more than one specimen with evidence of parasitemia had nonconsecutive positives. Several enrollees likely had been infected at least 1 year when their last positive specimen was collected. The final three specimens for seven persons tested negative by all study methods, including IFA.
CONCLUSION: Seropositive blood donors can have protracted low-level parasitemia that is variably and intermittently detected by parasitologic and molecular methods. Donor-screening algorithms should include serologic testing and not solely rely on molecular testing.
© 2014 AABB.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24673297      PMCID: PMC4772885          DOI: 10.1111/trf.12622

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  30 in total

1.  The third described case of transfusion-transmitted Babesia duncani.

Authors:  Evan M Bloch; Barbara L Herwaldt; David A Leiby; Annette Shaieb; Ross M Herron; Michael Chervenak; William Reed; Robert Hunter; Rosilyn Ryals; Ward Hagar; Maniphet V Xayavong; Susan B Slemenda; Norman J Pieniazek; Patricia P Wilkins; Anne M Kjemtrup
Journal:  Transfusion       Date:  2011-12-13       Impact factor: 3.157

2.  Human babesiosis.

Authors:  Edouard Vannier; Peter J Krause
Journal:  N Engl J Med       Date:  2012-06-21       Impact factor: 91.245

3.  Transfusion-associated babesiosis: shouldn't we be ticked off?

Authors:  David A Leiby
Journal:  Ann Intern Med       Date:  2011-09-05       Impact factor: 25.391

4.  Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Authors:  Laura Tonnetti; Aaron M Thorp; Heather L Reddy; Shawn D Keil; Raymond P Goodrich; David A Leiby
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

Review 5.  Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti.

Authors:  David A Leiby
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

6.  Lookback investigations of Babesia microti-seropositive blood donors: seven-year experience in a Babesia-endemic area.

Authors:  Stephanie T Johnson; Ritchard G Cable; David A Leiby
Journal:  Transfusion       Date:  2011-09-12       Impact factor: 3.157

7.  Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program.

Authors:  Carolyn Young; Anjulika Chawla; Victor Berardi; James Padbury; Gail Skowron; Peter J Krause
Journal:  Transfusion       Date:  2012-03-27       Impact factor: 3.157

8.  Babesiosis surveillance - 18 States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-07-13       Impact factor: 17.586

9.  Transfusion-associated babesiosis in the United States: a description of cases.

Authors:  Barbara L Herwaldt; Jeanne V Linden; Elizabeth Bosserman; Carolyn Young; Danuta Olkowska; Marianna Wilson
Journal:  Ann Intern Med       Date:  2011-09-05       Impact factor: 25.391

10.  Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.

Authors:  Laura Tonnetti; Melanie C Proctor; Heather L Reddy; Raymond P Goodrich; David A Leiby
Journal:  Transfusion       Date:  2009-12-18       Impact factor: 3.157

View more
  13 in total

Review 1.  Transfusion-transmitted babesiosis: is it time to screen the blood supply?

Authors:  Andrew E Levin; Peter J Krause
Journal:  Curr Opin Hematol       Date:  2016-11       Impact factor: 3.284

2.  Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model.

Authors:  Sanjeev Gumber; Fernanda S Nascimento; Kenneth A Rogers; Henry S Bishop; Hilda N Rivera; Maniphet V Xayavong; Sushil G Devare; Gerald Schochetman; Praveen K Amancha; Yvonne Qvarnstrom; Patricia P Wilkins; François Villinger
Journal:  Transfusion       Date:  2016-02-19       Impact factor: 3.157

3.  Development of a Multiplex Bead Assay To Detect Immunoglobulin G Antibodies to Babesia duncani in Human Serum.

Authors:  Yong Wang; TaLesa Aderohunmu; Henry Bishop; Isabel McAuliffe; Hilda N Rivera; Darlyne Smith; Patricia P Wilkins; Katherine E Bowden; Matthew S Reed; Pavel Svoboda; Olga Stuchlik; Jan Pohl; Ryan E Wiegand; Sukwan Handali
Journal:  J Clin Microbiol       Date:  2021-08-25       Impact factor: 5.948

4.  Specific and Sensitive Diagnosis of Babesia microti Active Infection Using Monoclonal Antibodies to the Immunodominant Antigen BmGPI12.

Authors:  Jacqueline Gagnon; Sushma Timalsina; Jae-Yeon Choi; Meenal Chand; Pallavi Singh; Pooja Lamba; Gauri Gaur; Anasuya C Pal; Sara Mootien; Luis A Marcos; Choukri Ben Mamoun; Michel Ledizet
Journal:  J Clin Microbiol       Date:  2022-08-30       Impact factor: 11.677

5.  A prospective evaluation of chronic Babesia microti infection in seroreactive blood donors.

Authors:  Evan M Bloch; Andrew E Levin; Phillip C Williamson; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; Roberta Bruhn; Tzong-Hae Lee; Leilani Montalvo; Hany Kamel; Michael P Busch
Journal:  Transfusion       Date:  2016-05-17       Impact factor: 3.157

6.  Transmission of Babesia microti Parasites by Solid Organ Transplantation.

Authors:  Meghan B Brennan; Barbara L Herwaldt; James J Kazmierczak; John W Weiss; Christina L Klein; Catherine P Leith; Rong He; Matthew J Oberley; Laura Tonnetti; Patricia P Wilkins; Gregory M Gauthier
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

Review 7.  Persistence of Babesia microti Infection in Humans.

Authors:  Evan M Bloch; Sanjai Kumar; Peter J Krause
Journal:  Pathogens       Date:  2019-07-17

Review 8.  The Impact of Emerging Infectious Diseases on Chinese Blood Safety.

Authors:  Miao He; Jingxing Wang; Limin Chen; Jing Liu; Peibin Zeng
Journal:  Transfus Med Rev       Date:  2016-11-04

9.  Performance Evaluation of a Prototype Architect Antibody Assay for Babesia microti.

Authors:  Kevin Cheng; Kelly E Coller; Christopher C Marohnic; Zachary A Pfeiffer; James R Fino; Randee R Elsing; Janet Bergsma; Marilee A Marcinkus; Alak K Kar; Orlando H Gumbs; Kathy S Otis; Jeffrey Fishpaugh; Phillip W Schultz; Mark R Pope; Alfredo R Narvaez; Susan J Wong; Susan Madison-Antenucci; Thomas P Leary; George J Dawson
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

10.  Serologic screening of United States blood donors for Babesia microti using an investigational enzyme immunoassay.

Authors:  Andrew E Levin; Phillip C Williamson; Evan M Bloch; Joan Clifford; Sherri Cyrus; Beth H Shaz; Debra Kessler; Jed Gorlin; James L Erwin; Neil X Krueger; Greg V Williams; Oksana Penezina; Sam R Telford; John A Branda; Peter J Krause; Gary P Wormser; Anna M Schotthoefer; Thomas R Fritsche; Michael P Busch
Journal:  Transfusion       Date:  2016-05-25       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.